Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study
- PMID: 36505897
- PMCID: PMC9731582
- DOI: 10.1080/20018525.2022.2153644
Hypoxemia and not hyperoxemia predicts worse outcome in severe COPD exacerbations - an observational study
Abstract
Objectives: For patients admitted with an acute exacerbation of COPD (AECOPD) and a need for supplementary oxygen therapy, to determine if peripheral oxygen saturation < 88% (hypoxemia) or >92% (hyperoxemia), within first 24 hours of admission, is associated with 'treatment failure' or fewer days alive and out of hospital within 14 days after admission.
Design: A retrospective multicenter observational study, reviewing consecutive data on SpO2, oxygen, and drug administration at three predefined time points, on adverse events in patients admitted with COPD between December 2019 and June 2020. Multivariable logistic regression analysis, Mann Whitney U- and Chi-square-test were used.
Setting: Acute hospital setting, across four different hospitals in the capital region of Denmark.
Participants: Patients with a confirmed diagnosis of COPD admitted with an acute exacerbation and an oxygen need within the first 24 hours admission.
Results: In total 289 COPD patients were included. The median age was 74.8 years [interquartile range (IQR):69.6 to 81.8], 191 were female and 132 patients experienced 'treatment failure'. A minimum of one episode of hypoxemia (SpO2 < 88%) within first 24 hours was associated with having a low number (≤4) of days alive and out of hospital within 14 days after admission: OR 2.4 (95%CI 1.2 to 4.8), p = 0.02, absolute risk 44% vs. 26% p = 0.01, Chi-square. Comparable results were observed after 30 days of follow-up: OR 2.6 (95% CI 1.0 to7.1), p = 0.05. A minimum of one measurement of hyperoxemia (SpO2 > 92%), within first 24 hours of admission was not associated with low number of days alive and out of hospital within 14 days OR 1.0 (95% CI 0.5 to 2.1) nor at 30 days.
Conclusion: For admitted patients with AECOPD, being hypoxemic ever within the first 24 hours after admission is associated with a substantially increased risk of a poor prognosis.
Keywords: AECOPD; Hypoxemia; admission; hyperoxemia; late respiratory failure; oxygen therapy; treatment failure.
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures


Similar articles
-
Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial.Lancet Respir Med. 2019 Aug;7(8):699-709. doi: 10.1016/S2213-2600(19)30176-6. Epub 2019 May 20. Lancet Respir Med. 2019. PMID: 31122894 Clinical Trial.
-
Hyperoxemia after reperfusion in cardiac arrest patients: a potential dose-response association with 30-day survival.Crit Care. 2023 Mar 6;27(1):86. doi: 10.1186/s13054-023-04379-9. Crit Care. 2023. PMID: 36879330 Free PMC article.
-
Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial.Int J Chron Obstruct Pulmon Dis. 2023 Apr 18;18:599-614. doi: 10.2147/COPD.S397782. eCollection 2023. Int J Chron Obstruct Pulmon Dis. 2023. PMID: 37096159 Free PMC article. Clinical Trial.
-
The effects of exposure to severe hyperoxemia on neurological outcome and mortality after cardiac arrest.Minerva Anestesiol. 2022 Oct;88(10):853-863. doi: 10.23736/S0375-9393.22.16449-7. Epub 2022 Mar 23. Minerva Anestesiol. 2022. PMID: 35319851
-
Towards standardized and clinically relevant definitions of hypoxemia and hyperoxemia in preterm infants: A systematic review.Paediatr Respir Rev. 2025 Mar 11:S1526-0542(25)00029-6. doi: 10.1016/j.prrv.2025.03.002. Online ahead of print. Paediatr Respir Rev. 2025. PMID: 40187897 Review.
Cited by
-
COPD Exacerbation: Why It Is Important to Avoid ICU Admission.J Clin Med. 2023 May 9;12(10):3369. doi: 10.3390/jcm12103369. J Clin Med. 2023. PMID: 37240474 Free PMC article. Review.
-
Prediction of 12-month exacerbation-related readmission in hospitalized patients with COPD: a single-center study in China.Eur J Med Res. 2025 Aug 20;30(1):773. doi: 10.1186/s40001-025-03042-z. Eur J Med Res. 2025. PMID: 40830811 Free PMC article.
-
Oxygen Therapy in COPD.Respir Care. 2023 Jul;68(7):998-1012. doi: 10.4187/respcare.10876. Respir Care. 2023. PMID: 37353334 Free PMC article.
-
Assessment of Initial Oxygenation Levels of Chronic Obstructive Pulmonary Disease (COPD) and Their Impact on Basis and Vital Tools: Retrospective Cohort Study From India.Cureus. 2024 Dec 10;16(12):e75470. doi: 10.7759/cureus.75470. eCollection 2024 Dec. Cureus. 2024. PMID: 39791024 Free PMC article.
References
-
- Pauwels RA, Rabe KF.. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 2004;364(Aug 14):4–9. - PubMed
-
- Decramer M, Janssens W.Chronic obstructive pulmonary disease and comorbidities.Lancet Respir [Internet]. 2021;1(1):73–83. - PubMed
-
- Chronic-obstructive-pulmonary-disease-(COPD) [Internet]. World Health Organization . 2020. Oct 24. [cited 2020 Oct 24]. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pul...)
-
- Andreassen H, Vestbo J. Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective. Eur Respir J. 2003;22(Supplement 46):2s–4s. - PubMed
LinkOut - more resources
Full Text Sources